AKT1 and gestational diabetes: It is remarkable that CSF could ameliorate genetic mice with gestational diabetes by promoting the phosphorylation of Akt, reducing cAMP accumulation, and decreasing hepatic gluconeogenesis [59], suggesting that CSF could be a potential drug candidate for gestational diabetes by activating Akt/PDE4B pathway.